tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO

Oncopeptides AB (ONCO) Revenue

Compare
2 Followers

Oncopeptides AB Revenue

Oncopeptides AB had a revenue of 13.27M in the quarter ending Mar 31, 2025, with 33.82%. This bring the company's revenue in the last twelve months to 39.84M, Decreased 25.89%. In the fiscal year ending Dec 31, 2024, Oncopeptides AB had annual revenue of 31.65M with -10.14% growth.
Revenue (ttm)
39.84M
Revenue Growth
1.72%
P/S Ratio
11.62
Revenue/Employee
kr395,600
Employees
80
Market Cap
kr367.60M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
31.65M-3.57M-10.14%
Dec 31, 2023
35.22M26.86M+321.54%
Dec 31, 2022
8.36M-109.94M-92.94%
Dec 31, 2021
118.30M+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis